Rossi, Ernesto
 Distribuzione geografica
Continente #
NA - Nord America 940
EU - Europa 736
AS - Asia 186
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1.889
Nazione #
US - Stati Uniti d'America 935
SE - Svezia 189
PL - Polonia 159
IT - Italia 133
CN - Cina 96
DE - Germania 60
IE - Irlanda 51
FR - Francia 49
SG - Singapore 36
IN - India 27
CI - Costa d'Avorio 24
GB - Regno Unito 23
RU - Federazione Russa 22
UA - Ucraina 14
FI - Finlandia 11
TR - Turchia 8
IR - Iran 7
CZ - Repubblica Ceca 6
CA - Canada 5
NL - Olanda 5
BE - Belgio 4
HK - Hong Kong 4
ES - Italia 3
JP - Giappone 3
VN - Vietnam 3
CH - Svizzera 2
NO - Norvegia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
EU - Europa 1
HR - Croazia 1
KR - Corea 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
Totale 1.889
Città #
Chandler 209
Warsaw 158
Ashburn 84
Fairfield 75
Dublin 51
Wilmington 45
New York 39
Houston 27
Seattle 26
Woodbridge 26
Abidjan 24
Cambridge 24
Marseille 24
Singapore 23
Princeton 22
Rome 21
Nanjing 20
San Mateo 20
Moscow 18
Ann Arbor 17
Boston 15
Dearborn 15
Beijing 14
Milan 14
Jacksonville 11
Redwood City 11
Falls Church 10
Bremen 9
Cattolica 9
Helsinki 9
Los Angeles 9
London 7
Nanchang 7
San Diego 6
Washington 6
Bari 5
Hebei 5
Izmir 5
Boardman 4
Brussels 4
Changsha 4
Hangzhou 4
Hong Kong 4
Kish 4
Kunming 4
Leawood 4
Winston Salem 4
Augusta 3
Brno 3
Dong Ket 3
Florence 3
Hefei 3
Jiaxing 3
Lanzo d'Intelvi 3
Paris 3
Prague 3
Redmond 3
Somma Vesuviana 3
Turin 3
Verbania 3
Bologna 2
Burlington 2
Castelnuovo di Garfagnana 2
Duncan 2
Fremont 2
Giovinazzo 2
Kocaeli 2
Legnano 2
Madrid 2
Mountain View 2
Norwalk 2
Phoenix 2
Pune 2
San Giuseppe Vesuviano 2
Shanghai 2
Shenyang 2
Tianjin 2
Tokyo 2
Acton 1
Amsterdam 1
Arlington 1
Atlanta 1
Auckland 1
Bern 1
Charleston 1
Chicago 1
Chiswick 1
Cupertino 1
Dallas 1
Edinburgh 1
Falkenstein 1
Foggia 1
Fuzhou 1
Gatineau 1
Gunzenhausen 1
Haikou 1
Hounslow 1
Islington 1
Kashan 1
Kuala Lumpur 1
Totale 1.253
Nome #
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real- world experience 266
Pembrolizumab as first-line treatment for metastatic uveal melanoma 266
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 143
SKIN-COBRA (Consortium for Brachytherapy data Analysis) ontology: The first step towards interdisciplinary standardized data collection for personalized oncology in skin cancer 71
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 70
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 67
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway 67
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 63
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 60
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 57
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 57
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer 55
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 52
Skin cancer triage and management during COVID-19 pandemic. 52
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 51
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 49
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. 48
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 45
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 45
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 45
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 44
Multidisciplinary ocular and periocular cancers meetings: implementation in a tertiary referral center and analysis over a 12-months period 41
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 39
The role of postoperative radiotherapy in eccrine porocarcinoma: a multidisciplinary systematic review 37
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab 31
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 27
Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study 25
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 24
The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review 15
The Role of Postoperative Radiotherapy in the Management of Dermatofibrosarcoma Protuberans: A Multidisciplinary Systematic Review 11
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment 9
Totale 1.932
Categoria #
all - tutte 9.142
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.142


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020313 0 28 31 67 23 31 34 10 23 9 49 8
2020/2021152 8 10 5 11 23 6 16 2 15 26 27 3
2021/2022249 26 10 6 31 14 11 9 33 14 10 32 53
2022/2023636 70 84 40 98 21 70 61 51 67 27 34 13
2023/2024343 17 78 27 22 18 57 31 9 1 15 34 34
2024/202522 15 7 0 0 0 0 0 0 0 0 0 0
Totale 1.932